GlassScriptPhysician profile
Chhavi Rai
NPI 1154550663
$1,400.09
in general payments reported to CMS, 2019-2025
16 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.97 · 2023: $19.73 · 2024: $795 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $248.04 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $223.01 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.27 | 2024-2025 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $148.79 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $128.76 | 2024 | Voquezna |
| Lilly USA, LLC | $118.82 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $75.84 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $69.68 | 2024 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $43.45 | 2024 | Spravato |
| Pfizer INC. | $36.77 | 2024-2025 | |
| Amgen INC. | $31.01 | 2024-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $26.89 | 2024 | |
| Corcept Therapeutics | $23.74 | 2025 | Korlym |
| Agios Pharmaceuticals, INC. | $23.56 | 2025 | Pyrukynd |
| Medtronic, INC. | $20.49 | 2024 | Intellis Adaptivestim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $17.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chhavi Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.